A 20-year-old Japanese man was referred because of severe tinued. On the other hand, the PLT count began to recover pancytopenia with 14% of abnormal blasts in hypocellular bone spontaneously. At that time, BM (No. 2, 9 February 1995) red blood cells (400 ml/day for 2 days) and was treated with antibiotics and granulocyte colony-stimulating factor (G-CSF, filgrastim, 3.0 g/kg/day for 5 days) against the neutropenic fever. Trilineage hematologic recovery was quickly obtained. Introduction BM (No. 3, 17 February and No. 4, 10 March 1995) showed recovery of hematopoiesis without any abnormal blasts. The MLL gene rearrangement in 11q23 translocation is conThereafter, this hematologic remission state continued for sidered to be closely related to leukemogenesis of some kinds about 3 months. On 14 May 1995, backache suddenly started. of hematologic malignancies, especially infantile leukemia, Physical examination revealed the presence of systemic lymacute monoblastic/myelomonoblastic leukemia and therapyphadenopathy, hepatosplenomegaly and gingival swelling. related leukemia.
red blood cells (400 ml/day for 2 days) and was treated with antibiotics and granulocyte colony-stimulating factor (G-CSF, filgrastim, 3.0 g/kg/day for 5 days) against the neutropenic fever. Trilineage hematologic recovery was quickly obtained. off level of trisomy 8 in this method is defined to be 1.0%,
Figure 1
The clinical course from the first episode of disease to the development of overt leukemia.
which is calculated by adding three standard deviations to the phase although 2.5% of abnormal cells showed trisomy 8 in that marrow sample. These results suggest that the 11q23 mean of the frequency in these cells from normal controls (data not shown). BM samples from three other patients withtranslocation associated with MLL gene rearrangement occurred in a sub-population carrying trisomy 8 and evolved out any abnormalities involving chromosome 8, which had been cryopreserved, were analyzed as controls. The three into an aggressive overt leukemia. We diagnosed this case as a MDS from the percentage of hybridization signals were not detected in 200 cells from these controls at all. blasts in No. 1 BM according to FAB classification. 7,8 However, myelodysplasia was not evident, and the period of 3 months seems to be too short to complete all the evolution from MDS to overt leukemia. Thus, the real diagnosis in Feb- Topoisomerase II inhibitor is recognized as a leukemogen was performed according to the method described by Yamamoto et al 10 (nested PCR). The mRNA of GAPDH was detected which leads to MLL translocations and secondary leukemia. 13 Because antibiotics, RBC transfusions and G-CSF were the as control for RNA integrity.
Two different sizes of MLL-AF9 fusion transcripts were main therapy and no cytotoxic agent was administered during the hypoplastic phase in our case, it is unclear why MLL gene detected in No. 5 BMMNC from the leukemic phase. Direct sequencing revealed that the longer product (278 bp) was genrearrangement occurred. This is the first report of a trisomy 8 clone which evolved erated by the fusion of MLL ex. 8 and AF9, and the shorter one (164 bp) with MLL ex. 7 and AF9 generated by alternative into one associated with MLL gene rearrangement, and this case is interesting in considering the genetic alterations assosplicing of MLL ex. 8. The sensitivity of detecting MLL-AF9 fusion transcripts was as high as 10 Detection of the chimeric MLL-AF9 gene products is shown. One tenth of the PCR products were electrophoresed on a 3% agarose gel and visualized with ethidium bromide. Primers used were as follows: first round PCR MLL-S: 5′-CAGCAAAGAGAGCAGTGTTGTG-3′; AF9-AS: 5′-TTGATGCATCCAGTTGTTATATCC-3′; second round PCR MLLex7-S: 5′-CATCCTCAGCACTCTCTCCAA-3′; AF9inner-AS: 5′-CCTTGTTGCCTGGTCTGGGAT-3′; GAPDH-S: 5′-ACGGATTTGGTCGTATTGGG-3′; GAPDH-AS: 5′-TGATTTTGGAGGGATCTCGC-3′. 
